Functions of NF-κB1 and NF-κB2 in immune cell biology
Tóm tắt
Two members of the NF-κB (nuclear factor κB)/Rel transcription factor family, NF-κB1 and NF-κB2, are produced as precursor proteins, NF-κB1 p105 and NF-κB2 p100 respectively. These are proteolytically processed by the proteasome to produce the mature transcription factors NF-κB1 p50 and NF-κB2 p52. p105 and p100 are known to function additionally as IκBs (inhibitors of NF-κB), which retain associated NF-κB subunits in the cytoplasm of unstimulated cells. The present review focuses on the latest advances in research on the function of NF-κB1 and NF-κB2 in immune cells. NF-κB2 p100 processing has recently been shown to be stimulated by a subset of NF-κB inducers, including lymphotoxin-β, B-cell activating factor and CD40 ligand, via a novel signalling pathway. This promotes the nuclear translocation of p52-containing NF-κB dimers, which regulate peripheral lymphoid organogenesis and B-lymphocyte differentiation. Increased p100 processing also contributes to the malignant phenotype of certain T- and B-cell lymphomas. NF-κB1 has a distinct function from NF-κB2, and is important in controlling lymphocyte and macrophage function in immune and inflammatory responses. In contrast with p100, p105 is constitutively processed to p50. However, after stimulation with agonists, such as tumour necrosis factor-α and lipopolysaccharide, p105 is completely degraded by the proteasome. This releases associated p50, which translocates into the nucleus to modulate target gene expression. p105 degradation also liberates the p105-associated MAP kinase (mitogen-activated protein kinase) kinase kinase TPL-2 (tumour progression locus-2), which can then activate the ERK (extracellular-signal-regulated kinase)/MAP kinase cascade. Thus, in addition to its role in NF-κB activation, p105 functions as a regulator of MAP kinase signalling.
Từ khóa
Tài liệu tham khảo
Medzhitov, 2001, Toll-like receptors and innate immunity, Nat. Rev. Immunol., 1, 135, 10.1038/35100529
Takeda, 2003, Toll-like receptors, Annu. Rev. Immunol., 21, 335, 10.1146/annurev.immunol.21.120601.141126
Zhang, 2001, Toll-like receptor-mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity, J. Clin. Invest., 107, 13, 10.1172/JCI11837
O'Neill, 2000, The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense, Immunol. Today, 21, 206, 10.1016/S0167-5699(00)01611-X
Wallach, 1999, Tumor necrosis factor receptor and Fas signaling mechanisms, Annu. Rev. Immunol., 17, 331, 10.1146/annurev.immunol.17.1.331
Weih, 2003, Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway, Immunol. Rev., 195, 91, 10.1034/j.1600-065X.2003.00064.x
Claudio, 2002, BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells, Nat. Immunol., 3, 958, 10.1038/ni842
Girardin, 2003, Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing, Trends Immunol., 24, 652, 10.1016/j.it.2003.10.007
Feldmann, 2001, Anti-TNFα therapy of rheumatoid arthritis: what have we learned?, Annu. Rev. Immunol., 19, 163, 10.1146/annurev.immunol.19.1.163
Karin, 2002, NF-κB in cancer: from innocent bystander to major culprit, Nat. Rev. Cancer, 2, 301, 10.1038/nrc780
Farrow, 2002, Inflammation and the development of pancreatic cancer, Surg. Oncol., 10, 153, 10.1016/S0960-7404(02)00015-4
Normark, 2003, Persistent infection with Helicobacter pylori and the development of gastric cancer, Adv. Cancer Res., 90, 63, 10.1016/S0065-230X(03)90002-9
Ghosh, 1998, NF-κB and Rel proteins: evolutionary conserved mediators of immune responses, Annu. Rev. Immunol., 16, 225, 10.1146/annurev.immunol.16.1.225
Marienfeld, 2003, RelB forms transcriptionally inactive complexes with RelA/p65, J. Biol. Chem., 278, 19852, 10.1074/jbc.M301945200
Bours, 1993, The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers, Cell, 72, 729, 10.1016/0092-8674(93)90401-B
Franzoso, 1992, The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB mediated inhibition, Nature (London), 359, 339, 10.1038/359339a0
Fujita, 1993, The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through p50 homodimers, Genes Dev., 7, 1354, 10.1101/gad.7.7b.1354
Gerondakis, 1993, The activity of a 70kDa IκB molecule identical to the carboxyl terminus of the p105 NF-κB precursor is modulated by protein kinase A, Cell Growth Differ., 4, 617
Inoue, 1992, IκBγ, a 70 kDa protein identical to the C-terminal half of p100 NF-κB: a new member of the IκB family, Cell, 68, 1109, 10.1016/0092-8674(92)90082-N
Karin, 2000, Phosphorylation meets ubiquitination: the control of NF-κB activity, Annu. Rev. Immunol., 18, 621, 10.1146/annurev.immunol.18.1.621
Yang, 2001, The essential role of MEKK3 in TNF-induced NF-κB activation, Nat. Immunol., 2, 620, 10.1038/89769
Takaesu, 2003, TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway, J. Mol. Biol., 326, 105, 10.1016/S0022-2836(02)01404-3
Liu, 2004, Ubiquitin ligases and the immune response, Annu. Rev. Immunol., 22, 81, 10.1146/annurev.immunol.22.012703.104813
Ben-Neriah, 2002, Regulatory functions of ubiquitination in the immune system, Nat. Immunol., 3, 20, 10.1038/ni0102-20
Silverman, 2001, NF-κB signaling pathways in mammalian and insect innate immunity, Genes Dev., 15, 2321, 10.1101/gad.909001
Hultmark, 2003, Drosophila immunity: paths and patterns, Curr. Opin. Immunol., 15, 12, 10.1016/S0952-7915(02)00005-5
Morisato, 1995, Signaling pathways that establish the dorsal–ventral pattern of the Drosophila embryo, Annu. Rev. Genet., 29, 371, 10.1146/annurev.ge.29.120195.002103
Silverman, 2000, A Drosophila IκB kinase complex required for Relish cleavage and antibacterial immunity, Genes Dev., 14, 2461, 10.1101/gad.817800
Stoven, 2000, Activation of the Drosophila NF-κB factor Relish by rapid endoproteolytic cleavage, EMBO Rep., 1, 347, 10.1093/embo-reports/kvd072
Stoven, 2003, Caspase-mediated processing of the Drosophila NF-κB factor Relish, Proc. Natl. Acad. Sci. U.S.A., 100, 5991, 10.1073/pnas.1035902100
Ishikawa, 1997, Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2, J. Exp. Med., 186, 999, 10.1084/jem.186.7.999
Scheinman, 1993, NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule, Mol. Cell. Biol., 13, 6089
Mercurio, 1993, p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction, Genes Dev., 7, 705, 10.1101/gad.7.4.705
Dobrzanski, 1995, Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100, Oncogene, 10, 1003
Solan, 2001, RelB cellular regulation and transcriptional activity are regulated by p100, J. Biol. Chem., 277, 1405, 10.1074/jbc.M109619200
Yilmaz, 2003, RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF, EMBO J., 22, 121, 10.1093/emboj/cdg004
Caamano, 1998, Nuclear Factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses, J. Exp. Med., 187, 185, 10.1084/jem.187.2.185
Franzoso, 1998, Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture, J. Exp. Med., 187, 147, 10.1084/jem.187.2.147
Senftleben, 2001, Activation by IKKα of a second evolutionary conserved, NF-κB signaling pathway, Science, 293, 1495, 10.1126/science.1062677
Yamada, 2000, Abnormal immune function of hematopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase, J. Immunol., 165, 804, 10.4049/jimmunol.165.2.804
Xiao, 2001, NF-κB-inducing kinase regulates the processing of NF-κB2 p100, Mol. Cell, 7, 401, 10.1016/S1097-2765(01)00187-3
Koike, 1996, The splenic marginal zone is absent in alymphoplastic aly mutant mice, Eur. J. Immunol., 26, 669, 10.1002/eji.1830260324
Yin, 2001, Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice, Science, 291, 2162, 10.1126/science.1058453
Miyawaki, 1994, A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice, Eur. J. Immunol., 24, 429, 10.1002/eji.1830240224
Kaisho, 2001, IκB kinase α is essential for mature B cell development and function, J. Exp. Med., 193, 417, 10.1084/jem.193.4.417
Regnier, 1997, Identification and characterization of an IκB kinase, Cell, 90, 373, 10.1016/S0092-8674(00)80344-X
Ling, 1998, NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176, Proc. Natl. Acad. Sci. U.S.A., 95, 3792, 10.1073/pnas.95.7.3792
Xiao, 2001, Retroviral oncoprotein Tax induces processing of NF-κB2/p100 in T cells: evidence for the involvement of IKKα, EMBO J., 20, 6805, 10.1093/emboj/20.23.6805
Derudder, 2003, RelB/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation, J. Biol. Chem., 278, 23278, 10.1074/jbc.M300106200
Gommerman, 2003, Lymphotoxin/LIGHT, lymphoid microenviroments and autoimmunedisease, Nat. Immunol. Rev., 3, 642, 10.1038/nri1151
Muller, 2003, Lymphotoxin β receptor induces sequential activation of distinct NF-κB factors via separate signaling pathways, J. Biol. Chem., 278, 12006, 10.1074/jbc.M210768200
Dejardin, 2002, The lymphotoxin-β receptor induces different pathways of gene expression via two NF-κB pathways, Immunity, 17, 525, 10.1016/S1074-7613(02)00423-5
Karrer, 2000, Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect in secondary lymphoid organs and functional B cell defect, Eur. J. Immunol., 30, 2799, 10.1002/1521-4141(200010)30:10<2799::AID-IMMU2799>3.0.CO;2-2
Ware, 1995, The ligands and receptors of the lymphotoxin system, Curr. Top. Microbiol. Immunol., 198, 175
Kayagaki, 2002, BAFF/BLys receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2, Immunity, 10, 515, 10.1016/S1074-7613(02)00425-9
Coope, 2002, CD40 regulates the processing of NF-κB2 p100 to p52, EMBO J., 21, 5375, 10.1093/emboj/cdf542
Mackay, 2003, BAFF and APRIL: a tutorial on B cell survival, Annu. Rev. Immunol., 21, 231, 10.1146/annurev.immunol.21.120601.141152
Zarnegar, 2004, Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways, Proc. Natl. Acad. Sci. U.S.A., 101, 8108, 10.1073/pnas.0402629101
Novack, 2003, The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis, J. Exp. Med., 198, 771, 10.1084/jem.20030116
Saitoh, 2003, TWEAK induces NF-κB2 p100 processing and long-lasting NF-κB activation, J. Biol. Chem., 278, 36005, 10.1074/jbc.M304266200
Saccani, 2003, Modulation of NF-κB activity by exchange of dimers, Mol. Cell, 11, 1563, 10.1016/S1097-2765(03)00227-2
Mordmuller, 2003, Lymphotoxin and lipopolysaccharide induce NF-κB p52 generation by a co-translational mechanism, EMBO Rep., 4, 82, 10.1038/sj.embor.embor710
Ekengren, 1999, Drosophila cecropin as an antifungal agent, Insect Biochem. Mol. Biol., 29, 965, 10.1016/S0965-1748(99)00071-5
Malinin, 1997, MAP 3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1, Nature (London), 385, 540, 10.1038/385540a0
Wajant, 2001, The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators, Cell. Signalling, 13, 389, 10.1016/S0898-6568(01)00160-7
Grammer, 2001, CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms, Adv. Immunol., 76, 61, 10.1016/S0065-2776(01)76019-1
Saito, 2003, Two carboxy-terminal activation regions of Epstein–Barr virus latent membrane protein 1 activate NF-κB through distinct signaling pathways in fibroblast cell lines, J. Biol. Chem., 278, 46565, 10.1074/jbc.M302549200
Tada, 2001, Critical roles of TRAF2 and TRAF5 in TNF-induced NF-κB activaiton and protection from cell death, J. Biol. Chem., 276, 36530, 10.1074/jbc.M104837200
Wang, 2001, TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature (London), 412, 346, 10.1038/35085597
Sun, 2004, The novel functions of ubiquitination in signaling, Curr. Opin. Cell Biol., 16, 1
Kovalenko, 2003, The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination, Nature (London), 424, 801, 10.1038/nature01802
Trompouki, 2003, CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members, Nature (London), 424, 793, 10.1038/nature01803
Liao, 2004, Regulation of the NF-κB inducing kinase by TRAF3-induced degradation, J. Biol. Chem., 279, 26243, 10.1074/jbc.M403286200
Atkinson, 2004, Latent membrane protein 1 of Epstein–Barr virus stimulates processing of NF-κB p100 to p52, J. Biol. Chem., 279, 51134
Fong, 2002, Genetic evidence for the essential role of β-transducin repeat-containing protein in the inducible processing of NF-κB2/p100, J. Biol. Chem., 277, 22111, 10.1074/jbc.C200151200
Amir, 2004, Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase, Oncogene, 23, 2540, 10.1038/sj.onc.1207366
Fong, 2002, S9, a 19 S proteasome subunit interacting with ubiquitinated NF-κB2/p100, J. Biol. Chem., 277, 40697, 10.1074/jbc.M205330200
Heusch, 1999, The generation of nfkb2 p52: mechanism and efficiency, Oncogene, 18, 6201, 10.1038/sj.onc.1203022
Liao, 2003, Regulation of NF-κB2/p100 processing by its nuclear shuttling, Oncogene, 22, 4868, 10.1038/sj.onc.1206761
Rayet, 1999, Aberrant rel/nfkb genes and activity in human cancer, Oncogene, 18, 6938, 10.1038/sj.onc.1203221
Ciana, 1997, Constitutive expression of lymphoma-associated NF-κB/Lyt-10 proteins is tumorigenic in murine fibroblasts, Oncogene, 14, 1805, 10.1038/sj.onc.1201015
Chang, 1995, Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators, Mol. Cell. Biol., 15, 5180, 10.1128/MCB.15.9.5180
Kim, 2000, Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes, Oncogene, 19, 1334, 10.1038/sj.onc.1203432
Westerheide, 2001, The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition, Mol. Cell. Biol., 21, 8428, 10.1128/MCB.21.24.8428-8436.2001
Lanoix, 1994, Overproduction of NF-κB2 (lyt-10) and c-Rel: a mechanism for HTLV-1 Tax-mediated trans-activation via the NF-κB signaling pathway, Oncogene, 9, 841
Eliopoulos, 2003, Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway, Oncogene, 22, 7557, 10.1038/sj.onc.1207120
Luftig, 2004, Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent non-canonical NF-κB activation, Proc. Natl. Acad. Sci. U.S.A., 101, 141, 10.1073/pnas.2237183100
Geleziunas, 1998, Human T cell leukemia virus type I Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases, Mol. Cell. Biol., 18, 5157, 10.1128/MCB.18.9.5157
Chu, 1998, The Tax oncoprotein of human T cell leukemia virus type I associates with and persistently activates IκB kinases containing IKKα and IKKβ, J. Biol. Chem., 273, 15891, 10.1074/jbc.273.26.15891
Hatzivassiliou, 2002, Cellular signaling pathways engaged by the Epstein–Barr virus transforming protein LMP1, Front. Biosci., 7, 319, 10.2741/hatziva
Wang, 2002, NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function, Nat. Cell Biol., 4, 888, 10.1038/ncb872
Hacker, 2002, Is NF-κB2/p100 a direct activator of programmed cell death?, Cancer Cell, 2, 431, 10.1016/S1535-6108(02)00213-1
Rice, 1992, The precursor of NF-κB p50 has IκB-like functions, Cell, 71, 243, 10.1016/0092-8674(92)90353-E
Ishikawa, 1998, Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p) 105 precursor (NF-κB1) but expressing p50, J. Exp. Med., 187, 985, 10.1084/jem.187.7.985
Liou, 1992, The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50, EMBO J., 11, 3003, 10.1002/j.1460-2075.1992.tb05370.x
Ciechanover, 2000, Ubiquitin-mediated proteolysis: biological regulation via destruction, Bioessays, 22, 442, 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q
Rape, 2002, Taking a bite: proteasomal protein processing, Nat. Cell Biol., 4, 113, 10.1038/ncb0502-e113
Lin, 1996, A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit, Mol. Cell. Biol., 16, 2248, 10.1128/MCB.16.5.2248
Betts, 1996, Differential regulation of NF-κB2 (p100) processing and control by amino-terminal sequences, Mol. Cell. Biol., 16, 6363, 10.1128/MCB.16.11.6363
Orian, 1999, Structural motifs involves in ubiquitin-mediated processing of the NF-κB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain, Mol. Cell. Biol., 19, 3664, 10.1128/MCB.19.5.3664
Levitskaya, 1997, Inhibition of ubiquitination/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1, Proc. Natl. Acad. Sci. U.S.A., 94, 12616, 10.1073/pnas.94.23.12616
Sharipo, 1998, A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: a new mechanism for selective inhibition of proteolysis, Nat. Med., 4, 939, 10.1038/nm0898-939
Lee, 2001, ATP-dependent proteases degrade their substrates by processively unraveling them for the degradation signal, Mol. Cell, 7, 627, 10.1016/S1097-2765(01)00209-X
Cohen, 2001, Processing of p105 is inhibited by docking of p50 active subunits to teh ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ubiquitin-ligase binding domain, J. Biol. Chem., 276, 26769, 10.1074/jbc.M102448200
Harhaj, 1996, Inhibition of p105 processing by NF-κB proteins in transiently transfected cells, Oncogene, 12, 2385
Maier, 2003, Critical role of RelB serine 368 for dimerization and p100 stabilization, J. Biol. Chem., 278, 39242, 10.1074/jbc.M301521200
Lin, 1998, Cotranslational biogenesis of NF-κB p50 by the 26 S proteasome, Cell, 92, 819, 10.1016/S0092-8674(00)81409-9
Fan, 1991, Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway, Nature (London), 354, 395, 10.1038/354395a0
Li, 2000, Cotranslational dimerization of the Rel homology domain of NF-κB1 generates p50–p105 heterodimers and is required for effective p50 dimerization, EMBO J., 19, 4712, 10.1093/emboj/19.17.4712
Donald, 1995, Proteolytic processing of NF-κB/IκB in human monocytes, J. Biol. Chem., 270, 9, 10.1074/jbc.270.1.9
Belich, 1999, TPL-2 kinase regulates the proteolysis of the NF-κB inhibitory protein NF-κB1 p105, Nature (London), 397, 363, 10.1038/16946
MacKichan, 1996, Phosphorylation of p105 PEST sequences via a redox-insensitive pathway up-regulates processing to p50 NF-κB, J. Biol. Chem., 271, 6084, 10.1074/jbc.271.11.6084
Mellits, 1993, Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of of NF-κB, Nucleic Acids Res., 21, 5059, 10.1093/nar/21.22.5059
Salmeron, 2001, Direct phosphorylation of NF-κB p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis, J. Biol. Chem., 276, 22215, 10.1074/jbc.M101754200
Lang, 2003, βTrCP-mediated proteolysis of NF-κB1 p105 requires phosphorylation of p105 serines 927 and 932, Mol. Cell. Biol., 23, 402, 10.1128/MCB.23.1.402-413.2003
Heissmeyer, 2001, Shared pathways of IκB kinase-induced SCFβTrCP-mediated ubiquitination and degradation for the NF-κB precursor p105 and IκBα, Mol. Cell. Biol., 21, 1024, 10.1128/MCB.21.4.1024-1035.2001
Beinke, 2002, The death domain of NF-κB1 p105 is essential for signal-induced p105 proteolysis, J. Biol. Chem., 277, 24162, 10.1074/jbc.M201576200
Heissmeyer, 1999, NF-κB p105 is a target on IkB kinases and controls signal induction of BCL-3–p50 complexes, EMBO J., 18, 4766, 10.1093/emboj/18.17.4766
Orian, 2000, SCFβTrCP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase, EMBO J., 19, 2580, 10.1093/emboj/19.11.2580
Syrovets, 2001, Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK-β-mediated NF-κB activation, Blood, 97, 3941, 10.1182/blood.V97.12.3941
Ten, 1992, The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation, EMBO. J., 11, 195, 10.1002/j.1460-2075.1992.tb05042.x
Cohen, 2004, Dual effects of IκB kinase β-mediated phosphorylation on p105 fate: SCFβ-TrCP-dependent degradation and SCFβ-TrCP-independent processing, Mol. Cell. Biol., 24, 475, 10.1128/MCB.24.1.475-486.2004
Wu, 2003, Structure of a β-TrCP1–Skp1–β-catenin complex: destruction motif binding and lysine specificity of the SCFβTrCP1 ubiquitin ligase, Genes Dev., 11, 1445
Demarchi, 2003, Glycogen synthase-3β regulates NF-κB1/p105 stability, J. Biol. Chem., 278, 39583, 10.1074/jbc.M305676200
Demarchi, 2001, Gas6 anti-apoptotic signaling requires NF-κB activation, J. Biol. Chem., 276, 31738, 10.1074/jbc.M104457200
Patriotis, 1993, Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T cell lymphomas and in T cell activation Proc, Natl. Acad. Sci. U.S.A., 90, 2251, 10.1073/pnas.90.6.2251
Miyoshi, 1991, Structure and transforming potential of the human cot oncogene encoding a putative protein kinase, Mol. Cell. Biol., 11, 4088
Salmeron, 1996, Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase, EMBO J., 15, 817, 10.1002/j.1460-2075.1996.tb00417.x
Dumitru, 2000, TNFα induction by LPS is regulated post-transcriptionally via a TPL2/ERK-dependent pathway, Cell, 103, 1071, 10.1016/S0092-8674(00)00210-5
Eliopoulos, 2002, Induction of COX-2 by LPS in macrophages is regulated by TPL2-dependent CREB activation signals, EMBO J., 21, 4831, 10.1093/emboj/cdf478
Eliopoulos, 2003, TPL-2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40, EMBO J., 22, 3855, 10.1093/emboj/cdg386
Beinke, 2003, NF-κB p105 negatively regulates TPL-2 MEK kinase activity, Mol. Cell. Biol., 23, 4739, 10.1128/MCB.23.14.4739-4752.2003
Lang, 2004, ABIN2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability, Mol. Cell. Biol., 24, 5235, 10.1128/MCB.24.12.5235-5248.2004
Waterfield, 2003, NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the TPL-2 kinase, Mol. Cell, 11, 685, 10.1016/S1097-2765(03)00070-4
Ceci, 1997, TPL-2 is an oncogenic kinase that is activated by carboxy-terminal truncation, Genes Dev., 11, 688, 10.1101/gad.11.6.688
Swantek, 1999, Lipopolysaccaride-induced tumor necrosis factor-α promoter activity is inhibitor of nuclear factor-κB kinase dependent, J. Biol. Chem., 274, 11667, 10.1074/jbc.274.17.11667
Chen, 2001, Tumor necrosis factor-α-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IκB kinase 1/2 in human alveolar epithelial cells, Mol. Pharmacol., 59, 493, 10.1124/mol.59.3.493
Caivano, 2001, The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein β (C/EBP β) and C/EBPδ transcript, J. Biol. Chem., 276, 48693, 10.1074/jbc.M108282200
Park, 2004, Targeting of TAK1 by the NF-κB protein Relish regulates the JNK-mediated immune response in Drosophila, Genes Dev., 18, 584, 10.1101/gad.1168104
Varfolomeev, 2004, Tumor necrosis factor: an apoptosis JuNKie?, Cell, 116, 491, 10.1016/S0092-8674(04)00166-7
Ferrier, 1999, Physical interaction of the bHLH LYL1 protein and NF-κB1 p105, Oncogene, 18, 995, 10.1038/sj.onc.1202374
Baer, 1993, TAL1, TAL2 and LYL1: a family of basic helix–loop–helix proteins implicated in T cell acute leukaemia, Semin. Cancer Biol., 4, 341
Li, 2003, Casper/c-FLIP is physically and functionally associated with NF-κB1 p105, Biochem. Biophys. Res. Commun., 309, 980, 10.1016/j.bbrc.2003.08.104
Krueger, 2001, FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis, Mol. Cell. Biol., 21, 8247, 10.1128/MCB.21.24.8247-8254.2001
Bouwmeester, 2004, A physical and functional map of the human TNFα/NF-κB signal transduction pathway, Nat. Cell Biol., 6, 97, 10.1038/ncb1086
van Huffel, 2001, Identification of a novel A20-binding inhibitor of nuclear factor-κB activation termed ABIN-2, J. Biol. Chem., 276, 30216, 10.1074/jbc.M100048200
Beyaert, 2000, A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis, Biochem. Pharmacol., 60, 1143, 10.1016/S0006-2952(00)00404-4
Lee, 2000, Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice, Science, 289, 2350, 10.1126/science.289.5488.2350
Sha, 1995, Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses, Cell, 80, 321, 10.1016/0092-8674(95)90415-8
Grumont, 1998, B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells, J. Exp. Med., 187, 663, 10.1084/jem.187.5.663
Sha, 1995, Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses, Cell, 80, 321, 10.1016/0092-8674(95)90415-8
Snapper, 1996, B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching, J. Immunol., 156, 183, 10.4049/jimmunol.156.1.183
Zheng, 2001, NF-κB RelA (p65) is essential for TNF-α-induced Fas expression but dispensable for both TCR-induced expression and activation-induced cell death, J. Immunol., 166, 4949, 10.4049/jimmunol.166.8.4949
Artis, 2003, NF-κB1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major, J. Immunol., 170, 1995, 10.4049/jimmunol.170.4.1995
Artis, 2002, Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation, J. Immunol., 169, 4481, 10.4049/jimmunol.169.8.4481
Das, 2001, A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation, Nat. Immunol., 2, 45, 10.1038/83158
Kanters, 2004, Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype, Blood, 103, 934, 10.1182/blood-2003-05-1450
Bohuslav, 1998, Regulation of an essential innate immune response by the p50 subunit of NF-κB, J. Clin. Invest., 102, 1645, 10.1172/JCI3877
Lamhamedi-Cherradi, 2003, Transcriptional regulation of type I diabetes by NF-κB, J. Immunol., 171, 4886, 10.4049/jimmunol.171.9.4886
Campbell, 2000, Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis, J. Clin. Invest., 105, 1799, 10.1172/JCI8298
Yang, 1998, Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation, J. Exp. Med., 188, 1739, 10.1084/jem.188.9.1739
Erdman, 2001, Typhlocolitis in NF-κB-deficient mice, J. Immunol., 166, 1443, 10.4049/jimmunol.166.3.1443
Karban, 2004, Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis, Hum. Mol. Genet., 13, 35, 10.1093/hmg/ddh008
Ishikawa, 1996, Charaterization of ES cells deficient for the p105 precursor (NF-κB1): role of p50 NLS, Oncogene, 13, 255
Liptay, 1992, Related subunits of NF-κB map to two distinct loci associated with translations in leukemia, NF-κB1 and NF-κB2, Genomics, 13, 287, 10.1016/0888-7543(92)90244-M
Bours, 1994, The NF-κB transcription factor and cancer: high expression of NF-κB, Biochem. Pharmacol., 47, 145, 10.1016/0006-2952(94)90448-0
Mukhopadhyay, 1995, Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma, Oncogene, 11, 999
Michaux, 1996, BCL3 rearrangement and t(14;19) (q32;q13) in lymphoproliferative disorders, Genes Chromosomes Cancer, 15, 38, 10.1002/(SICI)1098-2264(199601)15:1<38::AID-GCC6>3.0.CO;2-5
Lenardo, 1994, Bcl-3-mediated nuclear regulation of the NF-κB transactivating factor, Immunol. Today, 15, 145, 10.1016/0167-5699(94)90308-5
Ong, 1998, Lymphadenopathy, splenomegaly and altered immunoglobulin production in BCL-3 transgenic mice, Oncogene, 16, 2333, 10.1038/sj.onc.1201771
Thornburg, 2003, Activation of nuclear factor-κB p50 homodimer/BCL-3 complexes in nasopharyngeal carcinoma, Cancer Res., 63, 8293
Sun, 1999, Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular IκB kinases, Oncogene, 18, 6948, 10.1038/sj.onc.1203220
Watanabe, 1993, HTLV-1 encoded Tax in association with NF-κB precursor p105 enhances nuclear localization of NF-κB p50 and p65 in transfected cells, Oncogene, 8, 2949
Hirai, 1992, Transcriptional activator Tax of HTLV-1 binds to the NF-κB precursor p105, Oncogene, 7, 1737
Munoz, 1994, Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3, J. Virol., 68, 8035, 10.1128/jvi.68.12.8035-8044.1994
Rousset, 1996, Effects on NF-κB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome, Nature (London), 381, 328, 10.1038/381328a0
Karin, 2004, The IKK NF-κB system: a treasure trove for drug development, Nat. Rev. Drug Discov., 3, 17, 10.1038/nrd1279
Sun, 2003, Deregulation of NF-κB and its upstream kinases in cancer, Cancer Metastasis Rev., 22, 405, 10.1023/A:1023733231406
Kontoyiannis, 2002, Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease, J. Exp. Med., 196, 1563, 10.1084/jem.20020281
Locksley, 2001, The TNF and TNF receptor superfamilies: integrating mammalian biology, Cell, 104, 487, 10.1016/S0092-8674(01)00237-9
Marshall, 1994, MAP kinase kinase kinase, MAP kinase kinase and MAP kinase, Curr. Opin. Gene. Dev., 4, 82, 10.1016/0959-437X(94)90095-7
Caamano, 2000, Identification of a role for NF-κB2 in the regulation of apoptosis and in maintainance of T cell-mediated immunity to Toxoplasma gondii, J. Immunol., 165, 5720, 10.4049/jimmunol.165.10.5720
Weih, 1997, Multifocal defects in immune responses in RelB-deficient mice, J. Immunol., 158, 5211, 10.4049/jimmunol.158.11.5211
Weih, 2001, Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines, J. Immunol., 167, 1909, 10.4049/jimmunol.167.4.1909
Weih, 1995, Multiorgan inflammation and hematopoietic abnormalities in mice with targeted disruption of RelB, a member of the NF-κB/Rel family, Cell, 80, 331, 10.1016/0092-8674(95)90416-6
Snapper, 1996, B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching, J. Exp. Med., 184, 1537, 10.1084/jem.184.4.1537
Burkly, 1995, Expression of relB is required for the development of thymic medulla and dendritic cells, Nature (London), 373, 531, 10.1038/373531a0
Paxian, 2002, Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2, and Bcl-3, Gastroenterology, 122, 1853, 10.1053/gast.2002.33651
Schwarz, 1997, Immunological defects in mice with a targeted disruption in Bcl-3, Genes Dev., 11, 187, 10.1101/gad.11.2.187
Matsumoto, 2002, Essential role of NF-κB-inducing kinase in T cell activation through the TCR/CD3 pathway, J. Immunol., 169, 1151, 10.4049/jimmunol.169.3.1151